Supplementary Figure 1 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaMyron S. Czuczman,Marek Trněný, Andrew Davies,Simon Rule,Kim M. Linton,Nina Wagner-Johnston,Randy D. Gascoyne,Graham W. Slack,Pierre Brousset,David A. Eberhard,Francisco J. Hernandez-Ilizaliturri,Gilles Salles,Thomas E. Witzig,Pier Luigi Zinzani,George W. Wright,Louis M. Staudt,Yandan Yang,P. Mickey Williams,Chih-Jian Lih,Jacqueline Russo,Anjan Thakurta,Patrick Hagner,Pierre Fustier,Dale Song,Ian D. Lewisopenalex（2023）引用 0|浏览1关键词Biomarker Analysis,Treatment OutcomesAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
